Advancing evidence-based strategies for hepatitis C elimination in Ethiopia
Jimma University hosted a dissemination workshop for the Delivering Strategy for Hepatitis C in Ethiopia (DISTENE) Project, funded by the UK National Institute for Health and Care Research (NIHR). The project aims to contribute to the elimination of hepatitis C virus (HCV) infection in Ethiopia through research, context-specific treatment strategies, and capacity development.
Led by the University of Dundee, the DISTENE project brings together UK institutions—including the Universities of Dundee and Bristol and NHS Tayside—with Ethiopian partners, including Jimma University, Addis Ababa University, the University of Gondar, the Armauer Hansen Research Institute (AHRI), and the Ethiopian Public Health Institute (EPHI).
The project generated evidence on the burden of HCV infection in Ethiopia using epidemiological and modelling approaches and developed care pathways tailored to the Ethiopian healthcare context. It also piloted interventions at Jimma University Medical Center (JUMC) and Jimma Health Center (JHC), exploring opportunities to improve access to hepatitis C screening, treatment, and care.
The workshop was officially opened by Dr. Hunde Ahmed, Chief Clinical Director (CCD) of Jimma University Institute of Health (JUIH). In his opening remarks, he congratulated the project team on its achievements and highlighted the project’s contribution to research, knowledge generation, and human resource development in an area of public health that has received insufficient attention. He also emphasized its role in strengthening international collaboration, enhancing Jimma University’s research profile, and supporting the University’s transition to autonomy.
Dr. Elias Ali Yesuf, the project’s Principal Investigator (PI), underscored the importance of the new evidence generated by the project and its potential to inform context-appropriate HCV care strategies in Ethiopia. He also highlighted the project’s contribution to developing the next generation of researchers, noting that it provided valuable opportunities for six PhD students.
Dr. Emabet Dagne presented key findings from the pilot study conducted at JUMC and JHC, highlighting practical lessons for strengthening hepatitis C services and improving the delivery of care within the Ethiopian health system.
Workshop participants commended the project for addressing an important yet often overlooked public health challenge. Discussions highlighted the need to strengthen routine HCV screening and treatment, improve attention to the intersection between hepatitis C and HIV, and expand access to services at primary healthcare level. Participants also emphasized the importance of strengthening referral and service linkages between primary healthcare facilities and JUMC to promote knowledge exchange, skills development, resource sharing, and collaborative care.
The DISTENE project demonstrates the value of international research partnerships in generating locally relevant evidence, strengthening institutional capacity, and informing practical strategies to address pressing public health challenges.
Together, we can advance equitable access to hepatitis C prevention, diagnosis, treatment, and care in Ethiopia.
